Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Phaos Technology Holdings Cayman PB Ratio?
Phaos Technology Holdings CaymanPOAS +4.22%8 PB Ratio is 0.68 as of Sep. 09, 2026, which is 39% below its 10-year median of 1.12. GuruFocus rates POAS with a GF Score™ of 8/100. The stock has 8 warning signs investors should review. Among 784 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks better than 88.78% on this metric.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Phaos Technology Holdings Cayman PB Ratio Related Terms
Phaos Technology Holdings Cayman PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's PB Ratio distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's PB Ratio falls into.
Phaos Technology Holdings Cayman PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Phaos Technology Holdings Cayman (POAS) has a PB Ratio of 0.68 as of Sep. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phaos Technology Holdings Cayman and its competitors. This is 39% below median its historical median of 1.12. Over the past decade, Phaos Technology Holdings Cayman's PB Ratio has ranged from 0.64 to 10.36. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #88 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 11.2%.
Is Phaos Technology Holdings Cayman's PB Ratio too high?
Phaos Technology Holdings Cayman's current PB Ratio of 0.68 is 39% below median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 10.36. The Medical Devices & Instruments industry median PB Ratio is 2.13. Phaos Technology Holdings Cayman's value of 0.68 is 68.1% below this industry median. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #88 out of 784 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's PB Ratio compare to NUWE and ADMT?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #88 out of 784 companies for PB Ratio. This places Phaos Technology Holdings Cayman in the top 11% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.13. Phaos Technology Holdings Cayman's value of 0.68 is 68.1% below this benchmark. Historically, Phaos Technology Holdings Cayman's own PB Ratio has ranged from 0.64 to 10.36 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 2.13, Phaos Technology Holdings Cayman has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.13, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phaos Technology Holdings Cayman's current PB Ratio of 0.68 is 68.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phaos Technology Holdings Cayman and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current PB Ratio is 0.68, which is 39% below median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current PB Ratio of 0.68. The current PB Ratio is 0.68, which is 39% below median its 10-year median of 1.12 and 68.1% below the Medical Devices & Instruments industry median of 2.13. Phaos Technology Holdings Cayman's overall GF Score™ is 8/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current PB Ratio is 0.68 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
8GF Score
Get the complete analysis for POAS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
